Frontiers

Understanding the Interplay Between Tumor Immune Microenvironment and Neoantigens for Improved Immunotherapy

The field of cancer immunotherapy has gained significant attention as a promising therapeutic approach, especially in light ...

Facioscapulohumeral Muscular Dystrophy Analysis Report 2025-2035: Market to Advance Rapidly, Driven by Breakthroughs in Genetic Research, Gene Therapy, and CRISPR-Based ...

Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic disorder marked by muscle weakness, primarily in the face, shoulders, and arms. The DUX4 gene mutation leads to toxic protein production, ...

Can we hear gravitational-wave 'beats' in the rhythm of pulsars?

Pulsars suggest that ultra–low-frequency gravitational waves are rippling through the cosmos. The signal seen by ...

'Powerhouse' green named one of the 'healthiest foods' may protect against cancer

A green vegetable has been ranked as one of the healthiest foods in the world - and it could even help protect against cancer ...

Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in ...

On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026TRX319 is an allogeneic CAR-Tr1 Treg cell therapy designed to pair ...